Liminatus Pharma (LIMN) Interest Coverage Ratio (2024 - 2026)
Liminatus Pharma (LIMN) posted Interest Coverage Ratio of 59.07 for Q1 2026, down 1239.66% sequentially from 5.18 in Q4 2025, and down 2482.31% YoY from 2.48 in Q1 2025.
Liminatus Pharma (LIMN) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Interest Coverage Ratio for 3 years, with the latest figure at 59.07 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 2482.31% year-over-year to 59.07 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 53.87 (up 1658.82% YoY) and the FY2025 annual result came in at 1.27, up 87.12% from the prior year.
- Interest Coverage Ratio declined to 59.07 in Q1 2026 per LIMN's latest filing, from 5.18 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 5.18 in Q4 2025 and troughed at 59.07 in Q1 2026.
- A 3-year average of 16.15 and a median of 8.82 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio surged 905.4% in 2025, then sank 2482.31% in 2026.
- Over 3 years, Interest Coverage Ratio stood at 0.64 in 2024, then surged by 905.4% to 5.18 in 2025, then sank by 1239.66% to 59.07 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 59.07, 5.18, and 36.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.42 |
| 10 | Liminatus Pharma | 257.00 Mn | 257.00 Mn | - | -73.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.07 |
| Dec 31, 2025 | 5.18 |
| Sep 30, 2025 | -36.80 |
| Jun 30, 2025 | -17.95 |
| Mar 31, 2025 | -2.29 |
| Dec 31, 2024 | -0.64 |
| Sep 30, 2024 | -5.86 |
| Jun 30, 2024 | -11.77 |